Teva Pharmaceutical to acquire Allergan Generics
Teva Pharmaceutical Industries, Ltd. announced Monday it has signed a definitive agreement with Allergan, PLC to acquire Allergan Generics in a transaction valued at $40.5 billion.The strategic acquisition brings together two leading generics businesses with complementary strengths, brands and cultures. Read More »
Alerts Sign-up